Stay updated with breaking news from Neck Cancers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A high rate of disease control was seen with the novel MDM2 inhibitor APG-115-alrizomadlin in patients with p53 wild-type salivary gland cancer.
Get latest articles and stories on Business at LatestLY. New Delhi [India], February 8: Health experts and leading oncologists of the country, highlighted the need for tailored interventions to address regional disparities for better management of Nasopharyngeal Carcinoma (NPC) in the country. They also urged to create relevant awareness around risk factors including, EBV Virus, smoking, poor oral hygiene and occupational exposure to Nitrosamine along with capacity building of doctors and healthcare set-ups for early detection and better treatment opportunities for NPC. Business News | Oncolo...
Drs Hanna and Kandula discuss the significance of the FDA approval of toripalimab in nasopharyngeal carcinoma; pivotal data from the JUPITER-02 and POLARIS-02 trials; and how this regulatory decision increases the importance of multidisciplinary collaboration.
/PRNewswire/ -- Precision Biologics, a clinical stage therapeutics company whose proprietary platform has produced highly targeted monoclonal antibodies, will...
Glenn J. Hanna, MD, discusses the significance of the FDA approval of toripalimab for patients with recurrent or metastatic nasopharyngeal carcinoma.